Artemis FAQs
Is a PSA blood test still necessary if using the Artemis/ProFuse platform?
Jul 12, 2023
Yes, a PSA blood test is still an important screening tool for prostate cancer detection. While the Artemis/ProFuse platform improves the accuracy and precision of biopsies, the PSA test remains valuable for initial screening. It is recommended to consult with Dr...
What are the benefits of using the Artemis/ProFuse platform for prostate cancer diagnosis and treatment?
Jul 12, 2023
The Artemis/ProFuse platform offers several benefits for prostate cancer diagnosis and treatment. It provides accurate and selective prostatic biopsies, reducing the number of biopsies required and minimizing the side effects of the investigation. For men with...
How does the Artemis platform differ from traditional prostate biopsy methods?
Jul 12, 2023
Traditional prostate biopsies have been performed using transrectal ultrasound-guided needle placement, which carries a risk of infection and may make accessing anteriorly placed lesions difficult. In contrast, the Artemis platform utilizes a transperineal approach,...
What is the Artemis/ProFuse platform, and how does it improve prostate cancer detection and diagnosis?
Jul 12, 2023
The Artemis/ProFuse platform is a system that combines 3D semi-robotic tracking and deformable MR-Ultrasound fusion to improve the accuracy and reliability of prostate cancer detection and diagnosis. It uses a mechanical robotic arm to stabilize and hold the...